Great good has come! New base drugs do not account for the proportion of drugs!

[China Pharmaceutical network industry trends] on October 25, the national health and Health Commission officially released the national essential drugs catalogue (2018 Edition), with the number of varieties increased to 685, 187 varieties transferred in and 22 varieties transferred out Among the introduced varieties, there are 12 anticancer drugs, including 3 small molecule targeted drugs and 2 monoclonal antibody drugs - exetinib, gefitinib, imatinib; rituximab and trastuzumab Drugs for chronic diseases, such as diabetes and hypertension, also have 9 and 8 new varieties Three generations of insulin, insulin glargine and GLP-1 analogues, such as lilalutide, are included (great good has come! New base drugs do not account for the proportion of drugs! Source: China Pharmaceutical net) according to relevant interpretation, these varieties are selected based on disease spectrum, incidence rate, disease burden and so on They meet the requirements of common diseases, chronic diseases, heavy burden, serious diseases, critical illness, public health and other basic drug use requirements, and also focus on Chinese Medicine (including ethnic medicine) and domestic innovative medicine On November 5, Heilongjiang Province and Liaoning Province successively issued a notice to deploy the implementation of national essential drugs catalogue (2018 Edition) Before that, 13 provinces and cities, including Shanxi, Guangdong, Fujian, Hebei, Hainan and Shandong, issued new versions of the drug base catalogue However, Liaoning Province has a strong incentive to use drugs, which never account for the proportion of drugs and are all on the Internet According to the notice on the implementation of national essential drugs catalogue 2018 (hereinafter referred to as "the notice") issued by Liaoning health and Family Planning Commission, national essential drugs are not included in the calculation of the proportion of drugs in public hospitals For the drugs that have been included in the national basic drug catalog and have not been put on the Internet in Liaoning Province, they will be put on the Internet in a timely manner through dynamic adjustment and other ways; the provincial drug purchase platform shall mark the national basic drugs and prompt the medical institutions for limited purchase At the same time, the information system of medical institutions should also mark the national basic drugs to ensure the limited use of doctors This time, by removing the restrictions on the proportion of basic drugs in Liaoning Province, it must be able to stimulate the enthusiasm of hospitals for the use of basic drugs to a certain extent In this context, the drugs in the new version of the basic drug list ushered in a better space This is especially true for products Some experts said that the state's attitude towards basic drugs is to give priority to the use of them According to the requirements of the previously released opinions on improving the national basic drug system, the basic drug will be used by public hospitals and doctors At the same time, the notice also stressed that we should adhere to the dominant position of basic drugs, and prompt medical institutions to purchase limited drugs and doctors to use limited drugs; guide medical institutions and volunteers to make reasonable diagnosis and treatment and rational use of drugs through the formulation of medical insurance payment standards and other ways According to the insiders, the market share of new base drug varieties can reach more than 150 billion yuan With the appearance of favorable effects of relevant policies, new varieties of base drugs will stir up hundreds of billions of markets However, it depends on whether the health insurance fund will pay for these basic drugs Based on the previous experience of "three medical linkage", the industry is not optimistic about it However, a careful study of the new version of the basic drug catalog, especially the new varieties, is not difficult to find that at the beginning of the catalog formulation, "three medical linkage" has been included Analysts believe that it is an inevitable trend for these varieties to enter health insurance through negotiation and price reduction in the future After the institutional reform, "three medical linkage" or has been integrated into the top-level design.